Discontinued — last reported Q4 '25
Other Income (Expense)
Other Income & ExpenseEli Lilly Other Income (Expense) increased by 18.6% to -$108.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.6%, from -$110.10M to -$108.30M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 41.5% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ1 2007
Last reportedQ4 2025
How to read this metric
Large fluctuations here often relate to market volatility or changes in the company's investment portfolio and debt structure.
Detailed definition
The net total of income and expenses from non-operating activities, such as interest income, interest expense, and gains...
Peer comparison
Companies with large cash piles often show significant interest income in this category.
Metric ID:
is_other_income_expense_netHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $190.50M | -$635.90M | -$77.30M | -$350.70M | -$119.20M | -$111.00M | $35.70M | -$36.80M | -$23.20M | $121.00M | $27.10M | -$197.60M | $62.00M | -$110.10M | -$239.00M | -$90.60M | -$133.10M | -$108.30M |
| QoQ Change | — | -433.8% | +87.8% | -353.7% | +66.0% | +6.9% | +132.2% | -203.1% | +37.0% | +621.6% | -77.6% | -829.2% | +131.4% | -277.6% | -117.1% | +62.1% | -46.9% | +18.6% |
| YoY Change | — | — | — | — | -162.6% | +82.5% | +110.2% | +69.1% | +79.1% | — | -24.1% | -437.0% | +367.2% | -191.0% | -981.9% | +54.1% | -314.7% | +1.6% |
Range-$635.90M – $190.50M
CAGR-12.4%
Avg YoY Growth-103.6%
Median YoY Growth+1.6%
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is Eli Lilly's other income (expense)?
- Eli Lilly (LLY) reported other income (expense) of -$108.30M in Q4 2025.
- How has Eli Lilly's other income (expense) changed year-over-year?
- Eli Lilly's other income (expense) increased by 1.6% year-over-year, from -$110.10M to -$108.30M.
- What is the long-term trend for Eli Lilly's other income (expense)?
- Over 3 years (2021 to 2025), Eli Lilly's other income (expense) has grown at a 41.5% compound annual growth rate (CAGR), from -$201.60M to -$571.00M.
- What does other income (expense) mean?
- Money made or lost from activities not related to the company's main business.